Autologous and Allogenic Transplantation With Campath-1H for T-Cell Lymphoma

NCT00505921 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

27

Enrollment

OTHER

Sponsor class

Stopped Slow Accrual.

Conditions

Lymphoma

Interventions

DRUG: Campath-1H
DRUG: G-CSF
DRUG: GM-CSF
DRUG: BCNU
DRUG: Stem Cell Transplant
DRUG: Preparative Regimen for Allogenic Stem Cell Transplantation
DRUG: Cytarabine
DRUG: Etoposide
DRUG: Melphalan
DRUG: Campath
DRUG: Fludarabine
DRUG: Cyclophosphamide
RADIATION: Low dose total body irradiation

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]